Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity

Susan E. Davidson, Catharine M L West, Stephen A. Roberts, Jolyon H. Hendry, Robert D. Hunter

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Biopsies from 89 patients with cervical carcinoma were studied using a clonogenic assay to obtain values for the surviving fraction at 2 Gy (SF2). Heterogeneity in intrinsic radiosensitivity was investigated by independently processing multiple biopsies from 18 tumors. No significant differences between intra-tumour SF2 values were demonstrated (p = 0.30). The results have shown that intra-tumour heterogeneity is not a limitation to radiosensitivity testing using the Courtenay-Mills assay. A wide range of values (0.13-0.97) for SF2 was obtained with a mean value of 0.47 ± 0.18 (±1 S.D., CV = 38%) for 52 squamous cell carcinomas and 0.59 ± 0.27 for four adenocarcinomas. There were statistically significant differences between the individual tumours (p <0.001). From the analysis-of-variance of all the SF2 results it appears to be the surviving fractions below about 0.40 and those above about 0.7 which show significant differences in radiosensitivity between pairs of tumours (p = 0.05). Also 36% of the values of SF2 show significant differences from the mean SF2 of all tumours. The storage of tumour cell suspensions in liquid nitrogen improved the colony-forming efficiency (CFE) but it did not alter the radiosensitivity. © 1990.
    Original languageEnglish
    Pages (from-to)349-356
    Number of pages7
    JournalRadiotherapy and Oncology
    Volume18
    Issue number4
    Publication statusPublished - Aug 1990

    Keywords

    • Cervix tumours
    • Heterogeneity
    • Radiosensitivity
    • SF2

    Fingerprint

    Dive into the research topics of 'Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity'. Together they form a unique fingerprint.

    Cite this